Literature DB >> 28130184

Amygdala-prefrontal cortex resting-state functional connectivity varies with first depressive or manic episode in bipolar disorder.

Shengnan Wei1, Haiyang Geng2, Xiaowei Jiang1, Qian Zhou3, Miao Chang2, Yifang Zhou4, Ke Xu2, Yanqing Tang5, Fei Wang6.   

Abstract

BACKGROUND: Bipolar disorder (BD) is one of the most complex mental illnesses, characterized by interactive depressive and manic states that are 2 contrary symptoms of disease states. The bilateral amygdala and prefrontal cortex (PFC) appear to play critical roles in BD; however, abnormalities seem to manifest differently in the 2 states and may provide further insight into underlying mechanisms.
METHODS: Sixteen participants with first-episode depressive and 13 participants with first-episode manic states of bipolar disorder as well as 30 healthy control (HC) participants underwent resting-state functional magnetic resonance imaging (fMRI). Resting-state functional connectivity (rsFC) between the bilateral amygdala and PFC was compared among the 3 groups.
RESULTS: Compared with depressive state participants of the BD group, manic state participants of the BD group showed a significant decrease in rsFC between the amygdala and right orbital frontal cortex (p<0.05, corrected). In addition, rsFC between the amygdala and left middle frontal cortex was significantly decreased in depressive and manic state participants of the BD group when compared with the HC group (p<0.05, corrected).
CONCLUSIONS: Our findings suggest that mood state during the first episodes of BD may be related to abnormality in hemispheric lateralization. The abnormalities in amygdala- left PFC functional connectivity might present the trait feature for BD, while deficits in amygdala- right PFC functional connectivity might be specific to manic episode, compared to depressive episode.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amygdala; Depressive; First episode; Functional connectivity; Manic; Prefrontal cortex; Resting state

Mesh:

Year:  2017        PMID: 28130184     DOI: 10.1016/j.neulet.2017.01.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Brain structure alterations in depression: Psychoradiological evidence.

Authors:  Fei-Fei Zhang; Wei Peng; John A Sweeney; Zhi-Yun Jia; Qi-Yong Gong
Journal:  CNS Neurosci Ther       Date:  2018-03-05       Impact factor: 5.243

2.  Na+, K+-ATPase α Isoforms and Endogenous Cardiac Steroids in Prefrontal Cortex of Bipolar Patients and Controls.

Authors:  Shiv Vardan Singh; Olga V Fedorova; Wen Wei; Haim Rosen; Noa Horesh; Asher Ilani; David Lichtstein
Journal:  Int J Mol Sci       Date:  2020-08-17       Impact factor: 5.923

3.  Obesity and Cerebral Blood Flow in the Reward Circuitry of Youth With Bipolar Disorder.

Authors:  Anahit Grigorian; Kody G Kennedy; Nicholas J Luciw; Bradley J MacIntosh; Benjamin I Goldstein
Journal:  Int J Neuropsychopharmacol       Date:  2022-06-21       Impact factor: 5.678

4.  Variation in rostral anterior cingulate functional connectivity with amygdala and caudate during first manic episode distinguish bipolar young adults who do not remit following treatment.

Authors:  Elizabeth T C Lippard; Wade Weber; Jeffrey Welge; Caleb M Adler; David E Fleck; Jorge Almeida; Melissa P DelBello; Stephen M Strakowski
Journal:  Bipolar Disord       Date:  2020-11-18       Impact factor: 5.345

5.  The Role of Amygdala in Patients With Euthymic Bipolar Disorder During Resting State.

Authors:  Gaizhi Li; Penghong Liu; Elissar Andari; Aixia Zhang; Kerang Zhang
Journal:  Front Psychiatry       Date:  2018-09-19       Impact factor: 4.157

6.  Resting-state functional connectivity of neural circuits associated with primary and secondary rewards in patients with bipolar disorder.

Authors:  Jing Shi; Hua Guo; Sijia Liu; Wei Xue; Fengmei Fan; Hongzhen Fan; Huimei An; Zhiren Wang; Shuping Tan; Fude Yang; Yunlong Tan
Journal:  Soc Cogn Affect Neurosci       Date:  2020-09-24       Impact factor: 3.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.